Literature DB >> 30297426

mTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level.

Hao Zeng1, Bo Lu1, Raffaella Zamponi1, Zinger Yang1, Kristie Wetzel1, Joseph Loureiro1, Sina Mohammadi1, Martin Beibel2, Sebastian Bergling2, John Reece-Hoyes1, Carsten Russ1, Guglielmo Roma2, Jan S Tchorz2, Paola Capodieci1, Feng Cong3.   

Abstract

Wnt/β-catenin signaling plays pivotal roles in cell proliferation and tissue homeostasis by maintaining somatic stem cell functions. The mammalian target of rapamycin (mTOR) signaling functions as an integrative rheostat that orchestrates various cellular and metabolic activities that shape tissue homeostasis. Whether these two fundamental signaling pathways couple to exert physiological functions still remains mysterious. Using a genome-wide CRISPR-Cas9 screening, we discover that mTOR complex 1 (mTORC1) signaling suppresses canonical Wnt/β-catenin signaling. Deficiency in tuberous sclerosis complex 1/2 (TSC1/2), core negative regulators of mTORC1 activity, represses Wnt/β-catenin target gene expression, which can be rescued by RAD001. Mechanistically, mTORC1 signaling regulates the cell surface level of Wnt receptor Frizzled (FZD) in a Dishevelled (DVL)-dependent manner by influencing the association of DVL and clathrin AP-2 adaptor. Sustained mTORC1 activation impairs Wnt/β-catenin signaling and causes loss of stemness in intestinal organoids ex vivo and primitive intestinal progenitors in vivo. Wnt/β-catenin-dependent liver metabolic zonation gene expression program is also down-regulated by mTORC1 activation. Our study provides a paradigm that mTORC1 signaling cell autonomously regulates Wnt/β-catenin pathway to influence stem cell maintenance.

Entities:  

Keywords:  CRISPR screen; Frizzled; intestinal stem cells; mTORC1 signaling; organoids

Mesh:

Substances:

Year:  2018        PMID: 30297426      PMCID: PMC6217415          DOI: 10.1073/pnas.1808575115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers.

Authors:  Javier Muñoz; Daniel E Stange; Arnout G Schepers; Marc van de Wetering; Bon-Kyoung Koo; Shalev Itzkovitz; Richard Volckmann; Kevin S Kung; Jan Koster; Sorina Radulescu; Kevin Myant; Rogier Versteeg; Owen J Sansom; Johan H van Es; Nick Barker; Alexander van Oudenaarden; Shabaz Mohammed; Albert J R Heck; Hans Clevers
Journal:  EMBO J       Date:  2012-06-12       Impact factor: 11.598

2.  Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.

Authors:  Hung Huynh; Huai-Xiang Hao; Stephen L Chan; David Chen; Richard Ong; Khee Chee Soo; Panisa Pochanard; David Yang; David Ruddy; Manway Liu; Adnan Derti; Marissa N Balak; Michael R Palmer; Yan Wang; Benjamin H Lee; Dalila Sellami; Andrew X Zhu; Robert Schlegel; Alan Huang
Journal:  Mol Cancer Ther       Date:  2015-02-27       Impact factor: 6.261

3.  Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.

Authors:  Yonghao Yu; Sang-Oh Yoon; George Poulogiannis; Qian Yang; Xiaoju Max Ma; Judit Villén; Neil Kubica; Gregory R Hoffman; Lewis C Cantley; Steven P Gygi; John Blenis
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

4.  Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases.

Authors:  Xiaomo Jiang; Olga Charlat; Raffaella Zamponi; Yi Yang; Feng Cong
Journal:  Mol Cell       Date:  2015-04-16       Impact factor: 17.970

5.  Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.

Authors:  Teruaki Fujishita; Koji Aoki; Heidi A Lane; Masahiro Aoki; Makoto M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

Review 6.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

7.  TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase.

Authors:  Huira Chong-Kopera; Ken Inoki; Yong Li; Tianqing Zhu; Francesc R Garcia-Gonzalo; Jose Luis Rosa; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2006-02-07       Impact factor: 5.157

8.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

9.  ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.

Authors:  Huai-Xiang Hao; Yang Xie; Yue Zhang; Olga Charlat; Emma Oster; Monika Avello; Hong Lei; Craig Mickanin; Dong Liu; Heinz Ruffner; Xiaohong Mao; Qicheng Ma; Raffaella Zamponi; Tewis Bouwmeester; Peter M Finan; Marc W Kirschner; Jeffery A Porter; Fabrizio C Serluca; Feng Cong
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

10.  Essential role of the Dishevelled DEP domain in a Wnt-dependent human-cell-based complementation assay.

Authors:  Melissa V Gammons; Trevor J Rutherford; Zachary Steinhart; Stephane Angers; Mariann Bienz
Journal:  J Cell Sci       Date:  2016-10-15       Impact factor: 5.285

View more
  16 in total

1.  The Conundrum of the Pericentral Hepatic Niche: WNT/-Catenin Signaling, Metabolic Zonation, and Many Open Questions.

Authors:  Jan S Tchorz
Journal:  Gene Expr       Date:  2020-09-22

2.  Rapamycin treatment correlates changes in primary cilia expression with cell cycle regulation in epithelial cells.

Authors:  Maha H Jamal; Ane C F Nunes; Nosratola D Vaziri; Ramani Ramchandran; Robert L Bacallao; Andromeda M Nauli; Surya M Nauli
Journal:  Biochem Pharmacol       Date:  2020-05-26       Impact factor: 5.858

Review 3.  Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited.

Authors:  Daniella C N Hall; Ralf A Benndorf
Journal:  Cell Mol Life Sci       Date:  2022-07-02       Impact factor: 9.207

Review 4.  Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer.

Authors:  Yagmur Azbazdar; Mustafa Karabicici; Esra Erdal; Gunes Ozhan
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 5.  Regulation of DNA duplication by the mTOR signaling pathway.

Authors:  Zhengfu He; Peter J Houghton; Terence M Williams; Changxian Shen
Journal:  Cell Cycle       Date:  2021-03-10       Impact factor: 4.534

Review 6.  Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?

Authors:  Anna Prossomariti; Giulia Piazzi; Chiara Alquati; Luigi Ricciardiello
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-04-22

7.  Regulation of colonic epithelial cell homeostasis by mTORC1.

Authors:  Takenori Kotani; Jajar Setiawan; Tasuku Konno; Noriko Ihara; Saki Okamoto; Yasuyuki Saito; Yoji Murata; Tetsuo Noda; Takashi Matozaki
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

Review 8.  Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis.

Authors:  Béla Kovács; Enikő Vajda; Előd Ernő Nagy
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

9.  Testicular expression of long non-coding RNAs is affected by curative GnRHa treatment of cryptorchidism.

Authors:  Faruk Hadziselimovic; Gilvydas Verkauskas; Beata Vincel; Michael B Stadler
Journal:  Basic Clin Androl       Date:  2019-12-27

10.  Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC.

Authors:  Hao Zeng; Johnny Castillo-Cabrera; Mika Manser; Bo Lu; Zinger Yang; Vaik Strande; Damien Begue; Raffaella Zamponi; Shumei Qiu; Frederic Sigoillot; Qiong Wang; Alicia Lindeman; John S Reece-Hoyes; Carsten Russ; Debora Bonenfant; Xiaomo Jiang; Youzhen Wang; Feng Cong
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.